Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01144182 · ClinicalTrials.gov registry record · NA
Veterans Affairs Lowering Readmission in Heart Failure
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT01144182: Completed NA study, sponsored by VA Office of Research and Development.
NCT01144182 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01144182, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
Heart failure (HF) greatly increases mortality and lowers quality of life (QOL). HF is the most common indication for readmission in older adults and the most frequent reason for 30-day readmission. Medications and restriction of dietary sodium constitute crucial therapy to lower HF recurrence. However, adherence to medications and dietary recommendations is low in HF patients. Nonadherence is often due to an interaction among the environment, the patient and providers. In the VALOR in Heart Failure Study, we will assess a novel quality improvement program (QIP) to improve HF care using a pretest-posttest design. This interdisciplinary theory-based prospective experimental study will target improving HF treatment using patient-based behavioral and checklist intervention, as well as provider and system-targeted checklists and treatment defaults (posttest or intervention phase); this will be compared to current best practice (CBP) evaluated in the pretest (pretest or pre-intervention) phase. It is hypothesized that the QIP, which intervenes on patient, provider and system levels, will improve QOL and lower HF recurrence compared to CBP.
Interventions
- BEHAVIORAL Comprehensive quality improvement program (QIP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01144182
The ClinicalTrials.gov registry entry for NCT01144182 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Comprehensive quality improvement program (QIP) is the first listed.
NCT01144182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01144182 about?
NCT01144182 is a clinical study titled "Veterans Affairs Lowering Readmission in Heart Failure". Heart failure (HF) greatly increases mortality and lowers quality of life (QOL). HF is the most common indication for readmission in older adults and the most frequent reason for 30-day readmission. Medications and restriction of dietary sodium constitute crucial therapy to lower HF recurrence. Howe...
What is the current status of trial NCT01144182?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2010-10. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01144182?
The interventions under investigation include: Comprehensive quality improvement program (QIP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01144182?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.